A Phase 1 Comparative Study of E2022 Current and New Patch Formulations
Clinical trial NCT02042729 · COMPLETED
Trial details
- NCT number
- NCT02042729
- Sponsor
- Eisai Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2012-10-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.